C07D 285/135
Nitrogen atoms
C07D285/135 (Nitrogen atoms) appears on 651 US grants and 418 published applications in this corpus.
Search patents in C07D- Granted patents
- 651
- Published applications
- 418
- Assignees
- 307
- Inventors
- 1,774
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 27 | 0 |
| 1977 | 35 | 0 |
| 1978 | 22 | 0 |
| 1979 | 26 | 0 |
| 1980 | 21 | 0 |
| 1981 | 29 | 0 |
| 1982 | 9 | 0 |
| 1983 | 12 | 0 |
| 1984 | 7 | 0 |
| 1985 | 12 | 0 |
| 1986 | 8 | 0 |
| 1987 | 10 | 0 |
| 1988 | 8 | 0 |
| 1989 | 11 | 0 |
| 1990 | 15 | 0 |
| 1991 | 11 | 0 |
| 1992 | 13 | 0 |
| 1993 | 12 | 0 |
| 1994 | 11 | 0 |
| 1995 | 11 | 0 |
| 1996 | 6 | 0 |
| 1997 | 6 | 0 |
| 1998 | 11 | 0 |
| 1999 | 9 | 0 |
| 2000 | 6 | 0 |
| 2001 | 11 | 4 |
| 2002 | 7 | 11 |
| 2003 | 9 | 16 |
| 2004 | 7 | 19 |
| 2005 | 7 | 19 |
| 2006 | 4 | 17 |
| 2007 | 13 | 23 |
| 2008 | 8 | 21 |
| 2009 | 12 | 18 |
| 2010 | 15 | 34 |
| 2011 | 21 | 23 |
| 2012 | 28 | 16 |
| 2013 | 17 | 21 |
| 2014 | 25 | 30 |
| 2015 | 14 | 18 |
| 2016 | 17 | 15 |
| 2017 | 13 | 17 |
| 2018 | 12 | 18 |
| 2019 | 20 | 15 |
| 2020 | 11 | 11 |
| 2021 | 9 | 14 |
| 2022 | 7 | 10 |
| 2023 | 3 | 7 |
| 2024 | 7 | 15 |
| 2025 | 6 | 3 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Sulphonyl urea derivatives as NLRP3 inflammasome modulators4 Nov 2025US 12,459,925 B2NodThera Limited
- Inhibitors12 Aug 2025US 12,384,772 B2Vivoryon Therapeutics N.V.
- Carbonic anhydrase inhibitors and antibiotics against multidrug resistant bacteria5 Aug 2025US 12,378,211 B2Purdue Research Foundation
- Alkene-containing amide compound and application thereof3 Jun 2025US 12,319,663 B2Jiangsu Yangnong Chemical Co., Ltd.
- Electrolyte solution additive for secondary battery, and non-aqueous electrolyte solution for lithium secondary battery and lithium secondary battery which include the same20 May 2025US 12,308,388 B2LG Energy Solution, Ltd.
- Adar1 inhibitors and methods of using the same16 Jul 2026US 2026/0200890 A1Aten Porus Lifesciences Pvt. Ltd.
- Inhibitor of PFKFB2 Kinase Activity and Cellular Glycolysis16 Apr 2026US 2026/0102379 A1
- Novel inhibitors1 Jan 2026US 2026/0001873 A1Vivoryon Therapeutics N.V.
- Carbonic anhydrase inhibitors and antibiotics against multidrug resistant bacteria23 Oct 2025US 2025/0328351 A1
- Herbicides and use thereof9 Jan 2025US 2025/0008959 A1Projini Agchem LTD
Most cited
By later US patents
- Aryl carbonyl derivatives as therapeutic agents152US 7,384,967 B2Novo Nordisk A/S · 2008
- Aryl carbonyl derivatives as therapeutic agents123US 7,541,373 B2Novo Nordisk A/S · 2009
- Modulators of ATP-binding cassette transporters106US 7,977,322 B2Vertex Pharmaceuticals Incorporated · 2011
- Pharmacologically active guanidine compounds97US 3,950,333 ASmith Kline & French Laboratories Limited · 1976
- Inhibitors of histone deacetylase91US 6,541,661 B1MethylGene Inc. · 2003